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Glypicans represent a family of six cell surface heparan sulfate proteoglycans in vertebrates. Although no specific in vivo
unctions have thus far been described for these proteoglycans, spontaneous mutations in the human and induced deletions
n the mouse glypican-3 (Gpc3) gene result in severe malformations and both pre- and postnatal overgrowth, known
linically as the Simpson–Golabi–Behmel syndrome (SGBS). Mice carrying mutant alleles of Gpc3 created by either targeted
ene disruption or gene trapping display a wide range of phenotypes associated with SGBS including renal cystic dysplasia,
entral wall defects, and skeletal abnormalities that are consistent with the pattern of Gpc3 expression in the mouse
mbryo. Previous studies in Drosophila have implicated glypicans in the signaling of decapentaplegic, a BMP homolog. Our
experiments with mice show a significant relationship between vertebrate BMP signaling and glypican function;
GPC3-deficient animals were mated with mice haploinsufficient for bone morphogenetic protein-4 (Bmp4) and their
offspring displayed a high penetrance of postaxial polydactyly and rib malformations not observed in either parent strain.
This previously unknown link between glypican-3 and BMP4 function provides evidence of a role for glypicans in vertebrate
limb patterning and skeletal development and suggests a mechanism for the skeletal defects seen in SGBS.
© 2000 Academic Press
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Golabi–Behmel syndrome.INTRODUCTION tions. Although heparan sulfate is found ubiquitously on
cell surfaces, these carbohydrates are carried predominantlyThe essential requirement of heparan sulfate glycosami-
noglycans for normal development has been emphasized
only recently by the discovery that mutations in heparan
sulfate biosynthesis cause significant developmental de-
fects in Drosophila (Bellaiche et al., 1998; Binari et al.,
1997; Hacker et al., 1997; Haerry et al., 1997), in mice
(Bullock et al., 1998), and in humans (Lind et al., 1998;
McCormick et al., 1998). This has stimulated interest in
understanding the potential functions of specific protein
gene products that bear these posttranslational modifica-
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All rights of reproduction in any form reserved.by the protein products of only two gene families, synde-
cans (Saunders et al., 1989) and glypicans (David et al.,
1990).
All members of the glypican family share a common
mechanism of attachment to the cell membrane through
glycosylphosphatidylinositol linkages, and the character-
ization of amino acid sequence homologies has suggested
the existence of subfamilies of structurally related verte-
brate glypicans (Paine-Saunders et al., 1999). Whether these
individual glypicans have distinct or a related function is
unknown; however, human mutations in a single glypican
gene, glypican-3 (Gpc3), result in an overgrowth phenotype
known as Simpson–Golabi–Behmel syndrome (SGBS). This
X-linked condition is characterized by both pre- and post-
natal overgrowth, a distinct facial appearance, macroglos-179
sia, and multiple anomalies, including cleft palate, congeni-
tal heart and renal defects, imperforate vagina, umbilical
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Gpc3 expression in the progress zone, in the anterior and
posterior necrotic zones, and in the interdigital web where
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180 Paine-Saunders et al.hernias, supernumerary nipples, vertebral and rib defects,
and postaxial polydactyly (Behmel et al., 1984; Garganta
and Bodurtha, 1992; Hughes-Benzie et al., 1992; Pilia et al.,
1996). Nothing is known about the mechanism by which
these in vivo mutations of Gpc3 lead to the described
phenotypic features in humans. Nonetheless, as described
in this study and elsewhere (Cano-Gauci et al., 1999),
GPC3-deficient mice recapitulate the SGBS phenotype and
therefore provide an excellent in vivo model system for
evaluating the functions of vertebrate glypicans.
Although the mechanism of action of vertebrate glypi-
cans is unknown, the function of the Drosophila glypican
dally has been evaluated genetically. These studies have
revealed a role for dally in both wingless (wg; the Drosoph-
ila ortholog of vertebrate Wnt) signaling during early em-
bryonic patterning (Lin and Perrimon, 1999; Tsuda et al.,
1999) and decapentaplegic (dpp; the Drosophila ortholog of
vertebrate bone morphogenetic proteins) signaling during
postembryonic morphogenesis (Jackson et al., 1997). The
mechanism of Dally function has not been experimentally
established; however, these findings are consistent with the
proposed function for heparan sulfate proteoglycans as
coreceptors for a number of growth factors in vitro. More-
ver, it is clear from the above studies that glypican
unctions are highly context and tissue dependent in Dro-
ophila and are likely to be similarly context dependent in
ertebrates. Therefore it is not obvious which signaling
athways might be impacted by the loss of function of a
pecific vertebrate glypican in any particular tissue during
evelopment. We have therefore chosen to focus on under-
tanding the function of GPC3 in the pathogenesis of a
ingle phenotypic trait in vertebrates, polydactyly.
Although commonly seen in human patients with SGBS,
his phenotype is never seen in GPC3-deficient mice. We
herefore speculated that these animals may represent a
ensitized strain for glypican function in limb development
nd that genetic interaction studies might point toward the
ignaling pathway(s) mediated by GPC3 in this tissue.
ndeed, as has been suggested by others, the identification
f genetic modifiers provides an important pathway to
nderstanding the cellular and genetic interactions under-
ying embryonic development and the pathogenesis of hu-
an malformations (Dunn et al., 1997; Erickson, 1996;
inter, 1996).
We have found that the distribution of Gpc3 expression
verlaps with the patterns of a number of gene products
mplicated in limb patterning and whose biological activi-
ies are known to be dependent in part on heparan sulfate
roteoglycans. These include fibroblast growth factors
FGFs) (Rapraeger et al., 1991; Yayon et al., 1991), Wnts (Lin
and Perrimon, 1999; Reichsman et al., 1996; Tsuda et al.,
1999), bone morphogenetic proteins (BMPs) (Jackson et al.,
1997; Ruppert et al., 1996), and members of the vertebrate
hedgehog family (The et al., 1999). In particular, Bmp4
expression in the developing limb is highly coincident withCopyright © 2000 by Academic Press. All rightit plays an active role in mediating critical apoptotic events
in the development of these structures. Furthermore, Bmp4
haploinsufficient mice show a phenotype implicating a role
for BMPs in anterior–posterior patterning (Dunn et al.,
1997). Therefore we decided to test genetically whether
GPC3 might be important in BMP4 signaling in the devel-
oping limb and have found a strong genetic interaction
between mutants of these two genes that result in a high
penetrance of both postaxial polydactyly and rib malforma-
tions. This study provides the first in vivo evidence of a role
for glypicans in vertebrate development and establishes a
previously unknown link between GPC3 and BMP4 func-
tion, which suggests a mechanism for the skeletal defects
seen in SGBS.
MATERIALS AND METHODS
Generation of mutant mice. A 7.5-kb genomic fragment con-
taining the first exon of Gpc3, which includes the signal peptide,
was isolated from a strain 129SV genomic library in the Lambda
FIX II vector (Stratagene) using a 59-specific probe from human
Gpc3 cDNA. The DNA targeting vector was constructed by replac-
ing the first exon of Gpc3 (from approximately 250 bp to just
ownstream of the first splice site) with the AscI fragment contain-
ng the PGK-neo gene from pKO SelectNeo V800 (Lexicon). This
esulted in a vector flanked with 5.5 kb of homologous sequence
pstream and 2.0 kb of homologous sequence downstream. Addi-
ionally, an RsrII fragment containing the RNA Pol II diphtheria
oxin gene from pKO SelectDT V840 (Lexicon) was inserted at the
9 end to facilitate negative selection. The targeting vector was
inearized with NotI before electroporation into RW4 ES cells.
418-resistant ES cell clones were screened for targeting by South-
rn blot analysis.
One targeted ES cell line, No. 108, was microinjected into
57Bl/6J blastocysts, resulting in multiple high-percentage chi-
eric mice. Chimeric males were mated to C57Bl/6J females (The
ackson Laboratory). Agouti offspring that inherited the targeted
llele (Gpc3tm108Sau) were backcrossed to either C57Bl/6J or C57Bl/
6-Bmp4tm1blh (The Jackson Laboratory). The Gpc3TgN(bgeo)ex136Ska allele
was recovered in a screen, as described previously (Skarnes et al.,
1995), whereby the pGT1.8TM vector inserted within the second
intron of Gpc3 in 129 Ola ES cells.
The Gpc3tm108Sau allele was identified by PCR using a Gpc3-specific
forward primer, Dx22099, 59-ATCTCCCAGCTAAGCTCCTT-39
(2187 to 2168), and reverse primer derived from the neo gene,
9-ATGCTCCAGACTGCCTTG-39, while the wild-type allele was
identified using a reverse primer designed from the deleted exon,
Dx22141, 59-CCCAAGCCTAGCAGCATC-39 (184–201). Details are
available on request. The Gpc3TgN(bgeo)ex136Ska allele was followed by
detection of the lacZ reporter gene contained in the gene trapping
vector (Skarnes et al., 1995), while Bmp4 knockout genotyping
(Winnier et al., 1995) and sex determination (Hogan et al., 1994) were
both done by PCR as described elsewhere.
Timed pregnancies were determined by visualization of a vaginal
plug which was defined as day 0.5.
Southern analysis. ES cell clones were harvested and genomic
DNA was prepared, restriction digested with HindIII and XbaI, and
fractionated by agarose gel electrophoresis (George and Hynes,s of reproduction in any form reserved.
1994). DNA was transferred to Zeta Probe (Bio-Rad) using alkaline
transfer and hybridized with Rapid-Hyb (Amersham) at 65°C for 1 h
using a random-labeled probe generated from a 0.5-kb EcoRV–XbaI
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181GPC3 in Limb Patterning and Skeletal Developmentgenomic fragment immediately 39 of the targeted sequence. The
hybridized targeted allele gives a restriction fragment of 2.1 kb
compared with the endogenous allele of 5.2 kb.
Western analysis. Heparan sulfate proteoglycans were ex-
tracted from embryonic day 16.5 mouse liver in 50 mM Tris–HCl
(pH 8.0), 0.15 M NaCl, 6 M urea, 1% Triton X-100, 1 mM EDTA,
1 mg/ml pepstatin, 0.25 mg/ml N-ethylmaleimide, 0.5 mM phenyl-
methylsulfonyl fluoride and purified by DEAE chromatography as
described elsewhere (Herndon and Lander, 1990). Heparitinase
(Sigma) digests (0.002 U/ml) were carried out in 20 mM Tris–HCl,
pH 7.5, 5 mM CaCl2 at 37°C. Following electrophoresis in 4–15%
SDS–PAGE gel (Bio-Rad) and electroblotting to Immobilon-P (Mil-
lipore), GPC3 was detected using a rabbit polyclonal antisera
generated against a synthetic peptide corresponding to murine
GPC3 amino acids 524–541.
X-gal staining of tissues. Whole embryos at day 11.5, or dis-
sected limbs also at day 11.5 and later, were fixed 30 min in 1%
formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl2, 5 mM EGTA,
0.02% NP-40 in PBS. Tissues were washed 33 30 min in 0.2%
NP-40 in PBS and stained overnight at 37°C in 1 mg/ml X-gal, 5
mM K3Fe(CN)6, 5 mM K4(CN)6, 2 mM MgCl2, 0.01% deoxycholate,
0.02% NP-40 in PBS. After staining, tissues were postfixed in 1%
formaldehyde, 0.2% glutaraldehyde in PBS for 1 h before dehydra-
tion to 30% saline/70% EtOH, sectioned in paraffin, and lightly
counterstained with eosin.
Skeleton preparations. Embryonic day 16.5 animals were fixed
and their skeletons were stained with alcian blue and alizarin red
and cleared with KOH/glycerine as described by McLeod (1980).
RESULTS AND DISCUSSION
Null Alleles of Glypican-3 Model Human SGBS
To evaluate the functions of GPC3 in vivo, we created
nd characterized two mutant Gpc3 alleles generated by
ndependent methods. The first allele, designated tm108,
as created by homologous recombination, resulting in
argeted deletion of both the transcriptional and the trans-
ational initiation sites, as well as nucleotides encoding the
ignal peptide and first 33 amino acids of the putative
ature protein (Fig. 1A). The second allele, designated
x136, was identified in a gene trap experiment designed to
dentify mutations in secreted or cell surface proteins
Skarnes et al., 1995). Insertion of the gene trap vector into
he second intron of Gpc3 was confirmed by sequence
analysis of 59 RACE products derived from a fusion tran-
script (Townley et al., 1997) (Fig. 1B). Both ES cell clones
were successfully transmitted through the germ line of
chimeric mice following blastocyst injection. To determine
the functional consequence of these mutations we evalu-
ated the presence of GPC3 protein in DEAE-purified pro-
teoglycan extracts from hemizygous mutant and wild-type
animals by Western blotting using an antipeptide antibody
recognizing the core protein of murine GPC3. While this
antiserum readily identified the GPC3 heparan sulfate
proteoglycan in wild-type extracts, as well as the core
protein following enzymatic removal of the heparan sulfateCopyright © 2000 by Academic Press. All rightFIG. 1. Gene targeting, trapping, and molecular characteriza-
tion. (A) Structure of the murine Gpc3 locus. In the targeting
vector the neo gene was flanked on the 59 side with 5.5 kb of
genomic DNA and on the 39 side with 2 kb of genomic DNA,
introducing a deletion of the first exon of Gpc3. The identified
probe hybridizes to a 2.2-kb HindIII/XbaI restriction fragment at
a correctly targeted locus (tm108) compared with a 5-kb HindIII
restriction fragment from the endogenous locus. (B) The trapped
allele of Gpc3 (Ex136) was the result of a random integration
event of the gene trapping vector pGT1.8TM within the second
intron of Gpc3 as indicated. Identification of the site of integra-
tion within the Gpc3 locus was determined by 59 RACE of the
resulting fusion transcript. (C) A rabbit polyclonal antiserum,
specific to a GPC3-derived peptide, detects the GPC3 proteogly-
can and its core protein (as well as a previously described lower
molecular weight fragment of GPC3) following heparitinase
digestion in extracts from wild type, but not in extracts from
either the targeted (tm108) or the trapped (Ex136) allele of
glypicans, thus indicating that both alleles are null mutations
for GPC3.s of reproduction in any form reserved.
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izygote (Gpc3/Y, 14/53). By the time of weaning, however,
t
q
3
h
a
r
r
t
n
S
S
o
c
h
a
i
1
s
r
s
e
a
a
l
A
r
t
182 Paine-Saunders et al.chains, no detectable GPC3 was found in extracts from
animals hemizygous for either mutant allele (Fig. 1C). In
contrast, immunostaining of the same blot with a mono-
clonal antibody recognizing the core protein of syndecan-1
detected similar levels of that heparan sulfate proteoglycan
in all extracts (data not shown). Therefore we have con-
cluded that both the tm108 and Ex136 alleles of Gpc3 are
functionally null alleles.
Consistent with the findings of Gpc3 mutations in hu-
ans, we found that mice bearing either the tm108 or the
x136 mutation displayed a range of phenotypic features
imilar to human patients with SGBS, and no obvious
ifferences between the phenotypes of mice bearing these
wo different alleles were observed (Fig. 2 and data not
hown). In particular, hemizygous male mouse embryos, of
ither allele, were 30% larger than wild-type littermate
ontrols (Fig. 2A), while heterozygous female animals (pre-
umably mosaic due to X inactivation) showed intermedi-
te growth properties.
Animals deficient for GPC3 also displayed medullary
ystic dysplasia of their kidneys (Fig. 2B) and a high fre-
uency of perinatal lethality, phenotypes reported in hu-
an patients with SGBS. On embryonic day 16.5, embryos
erived from heterozygous female (129SVJ/C57B16) and
ild-type male (C57B16) matings were found at the ex-
ected Mendelian ratios including 51% wild type (1/1,
FIG. 2. Mice bearing mutant alleles of Gpc3 recapitulate many of
the phenotypic features of human patients with Simpson–Golabi–
Behmel syndrome. (A) Male embryonic day 16.5 embryos, bearing
either hemizygous Ex136 (column 4) or tm108 (column 5) mutant
alleles weigh approximately 30% larger (P , 0.0001) than wild-
type littermate controls (column 1), while heterozygous females for
either the Ex136 (column 2) or the tm108 (column 3) allele show
intermediate growth properties (P , 0.0001). (B) The kidneys of
Gpc3 mutants show disregulated development of the collecting
system resulting in cystic (arrowhead) medullar changes of the
renal parenchyma. (C and D) Subtle skeletal abnormalities are
apparent in Gpc3-deficient animals, including bifurcations of the
xyphoid process as seen in D compared with a wild-type littermate
control in C.Copyright © 2000 by Academic Press. All righthere was a significant deviation from the expected fre-
uency of affected animals with 58% wild type (1/1,
9/67), 25% heterozygote (Gpc3/1, 17/67), and only 16%
emizygote (Gpc3/Y, 11/67). The majority of these deaths
ppear to occur within the first 2 days of life, but the
easons for this lethality have not been addressed.
Some of these phenotypic features have recently been
eported by another group who has independently targeted
he Gpc3 allele (Cano-Gauci et al., 1999). However, a
umber of additional phenotypic traits seen in human
GBS were also apparent in our mutant alleles of Gpc3.
pecifically, we found that ventral wall closure defects
ccur with incomplete penetrance (33%, n 5 12). In most
ases these consisted of small- to moderate-sized umbilical
erniations but in one stillborn animal this was manifested
s an omphalocele. In addition, stained skeletal prepara-
FIG. 3. Expression of the Gpc3 promoter is dynamically regulated
n the developing limb as reflected by the distribution of
b-galactosidase expression from the trapped Ex136 allele. Whole-
mount b-galactosidase staining of embryonic day 11.5 (A–E), day
2.5 (F), and day 13.5 (G) limbs, followed by paraffin infiltration and
ectioning (C–G). Gpc3 is not expressed in the apical epidermal
idge (AER) as seen in whole mount (A and B) or longitudinal
ection (arrowheads). At embryonic day 11.5, Gpc3 is intensely
xpressed in the distal mesenchyme and in the proximal anterior
nd posterior limb bud as seen in longitudinal section (D) and is
symmetrically expressed preferentially in the dorsal third of the
imb bud as seen in cross section at a level just below the AER (E).
t later stages (F and G), Gpc3 expression becomes restricted to
egions of cartilage differentiation in developing bone and within
he interdigital webs. a, anterior; p, posterior; d, dorsal; v, ventral.s of reproduction in any form reserved.
tions revealed subtle malformations in GPC3-deficient
pups, including bifurcations of the xyphoid process (Figs.
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183GPC3 in Limb Patterning and Skeletal Development2C and 2D). The identification of these additional traits
further supports the validity of murine GPC3 deficiency as
a model for human SGBS and the potential value of these
animals in understanding the mechanism of GPC3 func-
tion. Given the complex nature of the SGBS phenotype, and
the evidence that the Drosophila glypican dally may have
multiple mechanisms of action which are both tissue and
developmental stage dependent (Jackson et al., 1997; Lin
and Perrimon, 1999; Tsuda et al., 1999), we chose to focus
on understanding the function of GPC3 in the development
of a single phenotypic trait, polydactyly.
Gpc3 Expression Is Dynamically Regulated during
Murine Limb Patterning
As a first step in evaluating the possible roles of GPC3 in
vertebrate limb patterning, we examined the normal distri-
bution of expression of Gpc3 during limb morphogenesis
using the b-galactosidase reporter allele Ex136. Preliminary
tudies (Paine-Saunders and Saunders, unpublished) have
stablished that expression of b-galactosidase from this
trapped allele faithfully recapitulates the normal expression
pattern of Gpc3 mRNA as detected by in situ hybridization.
Gpc3 expression in the developing limb was seen to be
ynamically regulated in association with limb patterning
vents. At early embryonic stages (embryonic day 11.5),
pc3 expression was clearly absent from the specialized
ignaling structure the apical epidermal ridge (AER) (Figs.
A, 3B, and 3C), yet was intensely expressed in the under-
ying mesenchyme which responds to inductive cues from
he AER. However, expression in the mesenchyme at this
tage was asymmetric. As seen in longitudinal sections,
pc3 expression was most intense in the regions of the
istal mesenchyme within the progress zone and within the
roximal anterior and posterior limb bud, regions which
ltimately define the anterior and posterior necrotic zones
ANZ and PNZ, respectively) (Fig. 3D). On cross section of
he limb bud at a level just proximal to the AER, it was
pparent that Gpc3 was asymmetrically expressed more
bundantly in the dorsum of the developing limb bud as
ell. Whether this pattern reflects positive regulation of
pc3 gene expression in these peripheral regions of the
imb mesenchyme or alternatively a suppression of Gpc3
xpression in the central condensing mesenchyme region
annot be currently distinguished.
At later developmental ages such as embryonic days 12.5
Fig. 3F) and 13.5 (Fig. 3G), glypican-3 expression was
estricted to the interdigital webs and the regions of chon-
rocytic differentiation of the developing bones.
GPC3 and BMP4 Mutations Interact to Result in
Postaxial Polydactyly and Other Skeletal Defects
A number of factors that regulate cell proliferation,
differentiation, or death have been implicated in vertebrateCopyright © 2000 by Academic Press. All rightnd tissue levels of IGF-II share several phenotypic features
ith SGBS, including postaxial polydactyly (Eggenschwiler
t al., 1997), there has been considerable speculation about
he potential role of GPC3 as a negative regulator of IGF-II
unction (Pellegrini et al., 1998; Pilia et al., 1996). However,
here has been no experimental evidence in support of this
ypothesis. Indeed, on the contrary it has been impossible
o demonstrate a direct physical interaction between the rat
PC3 core protein and IGF-II (Song et al., 1997), as was
nitially reported for human GPC3 (Pilia et al., 1996).
urthermore, recent experiments have found no alteration
n tissue or serum levels of IGF-II in embryonic GPC3-
eficient animals (Cano-Gauci et al., 1999), a result that we
ave independently confirmed by quantitative radioimmu-
oassay (data not shown).
In contrast, there is considerable in vitro evidence for a
eneral role of heparan sulfate proteoglycans in the signal-
ng of a number of developmentally important growth
actors with spatial patterns of action that overlap with the
istribution of Gpc3 expression. These include FGFs in the
rogress zone, Wnts in the dorsal limb bud, and BMPs
ithin the ANZ, PNZ, and interdigital web. Furthermore,
s discussed above, there is evidence clearly supporting a
ole for the invertebrate glypican dally in either wg or dpp
ignaling in the context of distinct developmental events in
rosophila (Jackson et al., 1997; Lin and Perrimon, 1999;
suda et al., 1999). Because of the overlapping expression
attern of GPC3 and BMP4, and the evidence of a role for
MP4 in anterior–posterior patterning (Dunn et al., 1997),
e tested genetically whether GPC3 might be important in
MP4 signaling in the developing limb.
Bmp4 homozygous deficient animals die during early
mbryonic development before limb morphogenesis (Win-
ier et al., 1995). Animals heterozygous for a targeted
isruption of the Bmp4 gene (Bmp4tm1blh), however, are
viable and display a haploinsufficient phenotype that in-
cludes defects in anterior–posterior limb patterning (Dunn
et al., 1997). In particular, it has been previously reported
that on the C57Bl/6 genetic background Bmp4 heterozy-
gotes display preaxial polydactyly of the right hindlimb
with 12% penetrance (Dunn et al., 1997). We have observed
similar results with these animals on a mixed 129SV/
C57Bl/6 background (Fig. 4F). But on closer inspection of
embryonic day 16.5 Bmp4 heterozygotes, we also observed
a small vestigial nubbin on the postaxial side of the right
forelimb with approximately 50% penetrance (Fig. 4B). This
nubbin typically showed little or no ossification (Fig. 4I,
arrowhead) and frequently was no longer visible on new-
born animals. When present at birth it typically formed an
ectopic nail at this location.
When animals were mated to produce animals heterozy-
gous for a disrupted Bmp4 allele and hemizygous for either
mutant Ex136 or tm108 Gpc3 allele, the nature and severity
of the limb phenotype changed dramatically. Now, 100% of
the animals showed some degree of polydactyly with vari-s of reproduction in any form reserved.
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In the hindlimb, the change in the polydactylous pheno-
type was even more dramatic. Here 66% of the animals had
184 Paine-Saunders et al.able severity (n 5 36). In the forelimbs, the phenotype
demonstrated a clear increase in the severity of the pheno-
type observed in Bmp4 heterozygous animals alone. Fre-
uently both forelimbs were associated with well-formed
ifurcations of the fifth digit (Figs. 4C and 4D). The redun-
ant structures in these animals contained ossified bone in
he form of an ectopic triphalangeal duplication branching
rom the fifth metatarsal bone (Fig. 4J), a defect never seen
n Bmp4 heterozygous mutants alone.
FIG. 4. Combined genetic deficiency for Gpc3 and haploinsuffi-
ciency for Bmp4 results in postaxial polydactyly. Forelimbs (A–D,
I) and hindlimbs (E–H, J, K) of embryonic day 16.5 mice bearing
heterozygous mutations for Bmp4 either alone or in combination
with hemizygous deficiencies for Gpc3. All animals bearing muta-
tions in Gpc3 alone show normal limb patterning (not shown) as do
the majority of animals haploinsufficient for Bmp4 mutations
alone (A and E), while 10% of Bmp4 haploinsufficient animals
display preaxial polydactyly of the right hindlimb and 50% display
a small vestigial postaxial nubbin (B, arrow) of the right forelimb.
This nubbin displays little to no ossification as shown by skeletal
preparation (I). In contrast, 100% of animals bearing either hemi-
zygous targeted (tm108) or trapped (Ex136) alleles, in combination
with a heterozygous mutation for Bmp4, develop postaxial poly-
dactyly. Forelimbs frequently reveal bilateral abnormalities involv-
ing more severe duplications of the fifth digit, which include
well-ossified triphalangeal duplications (J, asterisk). The hindlimbs
of these animals display postaxial polydactyly with 66% pen-
etrance, and all display well-patterned and ossified duplications of
the terminal fifth digit (K, asterisk). There were no differences in
severity or penetrance of these phenotypes between either allele of
Gpc3.Copyright © 2000 by Academic Press. All rightpostaxial polydactyly, primarily of the right hindlimb, of a
form similar to that which is seen in human patients with
SGBS. The expressivity of this phenotype was complete,
with all animals displaying well-formed branched bifurca-
tions of the fifth digit identical to those shown in Figs. 4G
and 4H and identical to those seen in human patients with
SGBS. Similar to the forelimb defects, these structures
contained ossified bone as well, containing an ectopic
triphalangeal digit bifurcating from a common fifth meta-
tarsal bone (Fig. 4K). We found no differences in severity or
penetrance of polydactyly whether the targeted tm108 or
the trapped Ex136 mutant allele of Gpc3 was combined
with heterozygotes for Bmp4. We therefore conclude that
these two alleles of Gpc3 are equivalent with respect to
limb patterning and, because they represent independently
generated mutant alleles of Gpc3, that the phenotypes seen
are specific to a loss of GPC3 function in combination with
a reduction in BMP4 function.
On close examination of the remainder of the skeletons
of the animals null for Gpc3 and heterozygous for Bmp4, we
determined that there were other significant skeletal abnor-
malities with apparently complete penetrance. These ani-
mals, compared with littermate controls (Figs. 5A and 5B),
had markedly abnormal chests with deformed and abnor-
mally fused ribs (Figs. 5C and 5D). In addition, these
animals were found to have dual ossification centers
throughout the length of their sternum (Fig. 5F). These
skeletal abnormalities were not seen in either Gpc3 null or
Bmp4 heterozygous animals alone and were apparent only
as a result of genetic interaction between these two mutant
alleles. Interestingly, these phenotypic features are quite
reminiscent of those reported in association with a ho-
mozygous deficiency of another Bmp gene, Bmp7 (Luo et
al., 1995). However, in contrast to the high penetrance of
this phenotype in animals deficient for Gpc3 and haploin-
sufficient for Bmp4, this feature was found inconsistently
in Bmp7-deficient animals. This may be consistent with
both the hypothesis that GPC3 is involved in a pathway
that impacts multiple BMP family members and the specu-
lation that some structurally related BMPs, such as BMP4
and BMP7, may display certain redundancies in function
during development (Dudley and Robertson, 1997; Katagiri
et al., 1998). However, we found that a genetic interaction
was not evident in all tissues in which GPC3 and BMP4 (or
other BMP genes) are coexpressed, suggesting that, like
Dally, GPC3 may function in a tissue-dependent manner.
GPC3 Modulation of BMP4 Signaling
This study represents the first genetic evidence of a role
for glypicans in the control of cellular responses to BMPs
during vertebrate development. Here we report that the loss
of GPC3 results in both enhanced and synthetic phenotypes
in association with BMP4 heterozygous deficiencies. As
outlined below, we believe that this genetic interactions of reproduction in any form reserved.
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regard has been the identification of genetic modifiers of
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185GPC3 in Limb Patterning and Skeletal Developmentargues for a direct role for GPC3 in the control of cellular
responses to BMP4.
Although controversy remains as to whether BMPs func-
tion through short-range interactions or over longer ranges
through the establishment of morphogenetic gradients, it is
clear that the quantity of BMP protein available in the
target tissue is critical for achieving the necessary develop-
mental response. This is evident from several studies which
have now established, in both vertebrate and invertebrate
species, patterning abnormalities associated with heterozy-
gous null mutants for BMPs, which presumably express half
the normal levels of these gene products (Dunn et al., 1997;
Green, 1968; Irish and Gelbart, 1987; Katagiri et al., 1998;
McPherron et al., 1999). Therefore, understanding the mo-
ecular mechanisms that modify the strength of BMP sig-
als or the cellular response to these signals in vivo is
ssential to deciphering the role of BMPs in the regulation
f morphogenesis.
One strategy that has been particularly effective in this
FIG. 5. Combined genetic deficiency for Gpc3 and haploinsuffi-
ciency for Bmp4 results in other skeletal abnormalities. Animals
bearing heterozygous null mutations for Bmp4 alone (A and B), as
well as animals bearing hemizygous null mutations for Gpc3 alone
(Fig. 2D and data not shown), have normally formed rib cages. In
contrast, all animals with combined deficiency for Gpc3 and
haploinsufficiency for Bmp4 display markedly abnormal chest
walls with multiple rib fusions (C and D) as well as dual ossifica-
tion centers of the sternum (F).Copyright © 2000 by Academic Press. All righthe phenotype of weak dpp alleles in Drosophila have been
dentified (Ferguson and Anderson, 1992a,b; Raftery et al.,
995), and the characterization of these gene products, and
heir vertebrate homologs, has led rapidly to new informa-
ion about the downstream signaling pathways activated by
MP and about the secreted proteins that modify BMP
ctivities. Significantly, the Drosophila glypican Dally has
een shown to modify Dpp function in at least some
ostembryonic developmental events in imaginal tissue
Jackson et al., 1997). In most of these tissues, mutations of
ally enhance the phenotype associated with reduced dpp
xpression while suppressing phenotypes associated with
ctopic dpp expression, and dally mutants display reduced
xpression of dpp target genes, suggesting that Dally di-
ectly affects cellular responses to Dpp. Similarly, we have
iscovered that loss of a vertebrate glypican, GPC3, modi-
es BMP4 function in the mouse limb. Interestingly, not
nly is this genetic interaction between Gpc3 and Bmp4
utants in mice particularly strong, but the polydactylous
henotype seen in these animals is identical to the pheno-
ype seen in human patients with Gpc3 deficiency alone.
aken together, the results of our studies and previous
ork in Drosophila demonstrate that the regulation of
ellular responses to BMP is an evolutionarily conserved
unction of glypicans.
There are multiple mechanisms by which Dally and
PC3 could function. For example, they could affect a
arallel signaling pathway that alters cellular responses to
MPs. Alternatively, they could more directly modulate
he BMP signaling pathway. By analogy with the role of
nother heparan sulfate proteoglycan, betaglycan, which
irectly potentiates TGF-b binding to its signaling receptor,
it has been suggested that Dally could function as a core-
ceptor for Dpp (Jackson et al., 1997) and GPC3 could have a
similar function with respect to BMP4 in the vertebrate
limb. Consistent with this model, Drosophila Dpp (Groppe
et al., 1998) and vertebrate BMP2, -3, -4, and -7 (Ruppert et
al., 1996; Sampath et al., 1987, 1992; Wang et al., 1988) all
ind to heparin with high affinity in vitro and therefore
ikely bind to heparan sulfate in vivo. However, the conse-
uence of this interaction to BMP function remains un-
lear. For example, although heparin potentiates the activ-
ty of BMP2 in a chick limb bud differentiation model in
itro, as would be expected if it were serving a coreceptor
unction, so does destruction of the N-terminal heparin
inding domain of BMP2 or addition of a peptide corre-
ponding to the N-terminal heparin binding domain of
MP2 in these same assays (Ruppert et al., 1996). These
atter results can be interpreted as evidence that at least
ome heparan sulfate-containing proteins actually seques-
er BMPs in vivo and serve to suppress rather than enhance
MP functions.
Another likely mechanism by which GPC3 could directly
ffect BMP4 activity in the developing limb could be
hrough regulation of the distribution or level of accumu-s of reproduction in any form reserved.
lation of a BMP antagonist, several of which are known to
bind to heparin with high affinity. In particular, the heparin
t
w
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B
dylinositol-anchored membrane heparan sulfate proteoglycan
from human lung fibroblasts. J. Cell Biol. 111, 3165–3176.
Dudley, A. T., and Robertson, E. J. (1997). Overlapping expression
186 Paine-Saunders et al.binding BMP antagonist Gremlin has recently been shown
to mediate the SHH/FGF4 feedback loop in vertebrate limb
buds through direct BMP antagonism (Zuniga et al., 1999).
Loss of the heparan sulfate proteoglycan GPC3 could result
in the increased accumulation and/or a broader distribution
of Gremlin protein in the developing limb fields, thus
resulting in an increase in signaling through this feedback
loop and therefore development of redundant postaxial
structures.
Further experimentation will be necessary to carefully
evaluate each of these hypotheses about the role of GPC3 in
BMP signaling and vertebrate limb patterning. This analysis
will not be trivial because heparan sulfate proteoglycans
have been ascribed with various other functions, both in
vitro and in vivo, and GPC3 has not yet been specifically
ested for these functions. The potential promiscuity with
hich GPC3 may carry out the regulation of cellular
rocesses introduces unique challenges to the understand-
ng of its in vivo function.
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